PMC:7736111 / 83872-84214
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 2076 | 333-341 | Species | denotes | patients | Tax:9606 |
| 2077 | 98-101 | Gene | denotes | CD4 | Gene:920 |
| 2078 | 107-110 | Gene | denotes | CD8 | Gene:925 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T494 | 0-342 | Sentence | denotes | These studies along with others thus suggest that robust activation followed by the exhaustion of CD4+ and CD8+ T cells may be responsible for the disease progression, while therapies like checkpoint inhibitors (anti-PD-1 antibody; NCT04268537) which may prevent T cell exhaustion and restore their functional state may benefit some patients. |